Skip to main content
Osh project, fighting TB
War in Gaza:: find out how we're responding
Learn more
Tuberculosis (TB) is one of the world’s biggest global health crises. Killing 1.3 million people in 2022, TB is the world’s second deadliest infectious disease after COVID-19.

Obsolete treatments, the lack of an effective vaccine, and the lack of suitable diagnostic tools make it difficult to control the global TB epidemic. In 2022, 7.5 million people across 192 countries and areas were diagnosed with TB.
Some gains have been made in recent years; the first new TB drugs in half a century and the trial of a shorter course of treatment for drug-resistant TB. But the harsh reality remains - 10.6 million people fell sick with TB and 410,000 developed multidrug-resistant TB (MDR-TB) in 2022, which is much harder to treat. Only about one-third of people with DR-TB accessed treatment in 2021. The majority go undiagnosed and therefore untreated.


Quick facts about tuberculosis

medicine for the treatment of drug resistant tuberculosis

MSF reveals cost of landmark TB clinical trial in push for drug-development cost transparency

Press Release 25 Apr 2024
Biosafety level 3 laboratory

Against stigma and drug-resistance: five years of treating tuberculosis in Ukraine

Project Update 22 Mar 2024
Vaishnavi's mother, Vishakha prepares TB medication

MSF launches unprecedented project to tackle under-diagnosed tuberculosis among children

Project Update 18 Mar 2024
EndTB clinical trial results

Landmark clinical trial redefines multidrug-resistant tuberculosis treatment options

Press Release 15 Nov 2023
Anam, 17-years-old DR-TB patient

Johnson & Johnson and Cepheid must pledge access to lifesaving TB medicines and tests

Press Release 12 Sep 2023
 Somaliland: MSF hands over MDR-TB project to the Ministry of Health Development.

Recovering from multidrug-resistant tuberculosis in Somaliland

Project Update 28 Jun 2023
Fighting HIV and TB dual epidemic

MSF hands over HIV and TB programme in Eswatini after 16 years

Voices from the Field 26 May 2023
Tuberculosis in Tondo, Manila - Ezra Acayan

Tackling tuberculosis in the slums of Manila

Project Update 10 Apr 2023
SMARRTT Out Patient | Maria Story

New safer and shorter drug-resistant TB treatment must be scaled up

Press Release 22 Mar 2023

We produce important research based on our field experience. So far, we have published articles in over 100 peer-reviewed journals. These articles have often changed clinical practice and have been used for humanitarian advocacy. Read all our Tuberculosis-related articles on our dedicated Field Research website.

View site
Osh project, fighting TB